According to recent filings covering the 90 days ending December 12, 2025, the three most significant insider holders at Agios Pharmaceuticals are Chief Medical Officer Sarah Gheuens (61.73K shares), Chief Financial Officer Cecilia Jones (33.87K shares), Chief Legal Officer James William Burns (28.65K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Jacqualyn A Fouse | 151,340 | 23 Jun, 2025 | |
| David P Schenkein | 126,242 | 17 Jun, 2024 | |
| Brian Goff | Chief Executive Officer | 123,528 | 12 Aug, 2025 |
| Sarah Gheuens | Chief Medical Officer | 61,727 | 13 Nov, 2025 |
| Cecilia Jones | Chief Financial Officer | 33,870 | 30 Sep, 2025 |
| John Maraganore | 30,028 | 24 May, 2022 | |
| James William Burns | Chief Legal Officer | 28,650 | 26 Jun, 2025 |
| Tsveta Milanova | Chief Commercial Officer | 26,122 | 26 Jun, 2025 |
| Jonathan Biller | Chief Financial Officer | 22,953 | 23 Feb, 2022 |
| David Scadden | 17,603 | 14 Nov, 2025 | |
| Maykin Ho | 17,032 | 23 Jun, 2025 | |
| Bruce Car | Chief Scientific Officer | 16,752 | 23 Feb, 2022 |
| Christopher Bowden | Chief Medical Officer | 15,487 | 22 Jun, 2021 |
| Cynthia Smith | 12,414 | 13 Aug, 2025 | |
| Rahul D. Ballal | 12,414 | 13 Aug, 2025 | |
| Richa Poddar | Chief Commercial Officer | 8,508 | 18 Oct, 2022 |
| Kaye I Foster-Cheek | 7,468 | 23 Jun, 2025 | |
| Darrin Miles | Chief Commercial Officer | 7,209 | 18 May, 2021 |
| Ian T Clark | 6,549 | 24 May, 2022 | |
| Paul J Clancy | 6,549 | 24 May, 2022 | |
| Jeffrey D Capello | 6,073 | 23 Jun, 2025 | |
| Adams Catherine Owen | 6,073 | 23 Jun, 2025 | |
| Theodore James Jr. Washburn | Principal Accounting Officer | 868 | 09 Sep, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Nov, 2025 | David Scadden | Common stock | A | 200 | $18.09 | 17,803 | D | M |
| 12 Nov, 2025 | David Scadden | Common stock | D | 200 | $43.84 | 17,603 | D | S |
| 11 Nov, 2025 | Sarah Gheuens | Common stock | A | 2,454 | $25.01 | 64,181 | D | M |
| 11 Nov, 2025 | Sarah Gheuens | Common stock | D | 2,454 | $43.78 | 61,727 | D | S |
| 30 Oct, 2025 | Sarah Gheuens | Common stock | A | 200 | $25.01 | 61,927 | D | M |
| 30 Oct, 2025 | Sarah Gheuens | Common stock | D | 200 | $43.81 | 61,727 | D | S |
| 27 Oct, 2025 | Sarah Gheuens | Common stock | A | 3,302 | $25.01 | 65,029 | D | M |
| 27 Oct, 2025 | Sarah Gheuens | Common stock | D | 3,302 | $43.92 | 61,727 | D | S |
| 08 Oct, 2025 | David Scadden | Common stock | A | 200 | $18.09 | 17,803 | D | M |
| 08 Oct, 2025 | David Scadden | Common stock | D | 200 | $41.00 | 17,603 | D | S |
| 30 Sep, 2025 | David Scadden | Common stock | A | 200 | $18.09 | 17,803 | D | M |
| 30 Sep, 2025 | David Scadden | Common stock | D | 200 | $40.00 | 17,603 | D | S |
| 26 Sep, 2025 | Cecilia Jones | Common stock | A | 7,472 | $0.00 | 37,521 | D | M |
| 26 Sep, 2025 | Cecilia Jones | - | - | 37,521 | D | |||
| 26 Sep, 2025 | Cecilia Jones | Common stock | D | 3,651 | $36.77 | 33,870 | D | S |
| 26 Sep, 2025 | Cecilia Jones | - | - | 33,870 | D | |||
| 05 Sep, 2025 | Theodore James Jr. Washburn | - | - | 868 | D | |||
| 05 Sep, 2025 | Theodore James Jr. Washburn | Common stock | D | 8,546 | $36.87 | 868 | D | S |
| 27 Aug, 2025 | David Scadden | Common stock | A | 200 | $18.09 | 17,803 | D | M |
| 27 Aug, 2025 | David Scadden | Common stock | D | 200 | $40.00 | 17,603 | D | S |